Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

INDRAPRASTHA MEDICAL vs DR. LAL PATHLABS - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    INDRAPRASTHA MEDICAL DR. LAL PATHLABS INDRAPRASTHA MEDICAL/
DR. LAL PATHLABS
 
P/E (TTM) x 14.0 56.7 24.7% View Chart
P/BV x 4.1 11.7 35.3% View Chart
Dividend Yield % 1.7 0.5 329.4%  

Financials

 INDRAPRASTHA MEDICAL   DR. LAL PATHLABS
EQUITY SHARE DATA
    INDRAPRASTHA MEDICAL
Mar-23
DR. LAL PATHLABS
Mar-23
INDRAPRASTHA MEDICAL/
DR. LAL PATHLABS
5-Yr Chart
Click to enlarge
High Rs942,870 3.3%   
Low Rs521,763 3.0%   
Sales per share (Unadj.) Rs119.9241.9 49.5%  
Earnings per share (Unadj.) Rs9.428.9 32.5%  
Cash flow per share (Unadj.) Rs13.746.9 29.2%  
Dividends per share (Unadj.) Rs3.0012.00 25.0%  
Avg Dividend yield %4.10.5 793.0%  
Book value per share (Unadj.) Rs41.4192.9 21.5%  
Shares outstanding (eoy) m91.6783.37 110.0%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x0.69.6 6.4%   
Avg P/E ratio x7.880.1 9.7%  
P/CF ratio (eoy) x5.349.4 10.8%  
Price / Book Value ratio x1.812.0 14.7%  
Dividend payout %31.941.5 76.9%   
Avg Mkt Cap Rs m6,694193,109 3.5%   
No. of employees `000NANA-   
Total wages/salary Rs m2,4673,765 65.5%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m10,98720,169 54.5%  
Other income Rs m100417 24.0%   
Total revenues Rs m11,08720,586 53.9%   
Gross profit Rs m1,5074,898 30.8%  
Depreciation Rs m3931,502 26.1%   
Interest Rs m43375 11.4%   
Profit before tax Rs m1,1723,438 34.1%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m3101,028 30.2%   
Profit after tax Rs m8622,411 35.7%  
Gross profit margin %13.724.3 56.5%  
Effective tax rate %26.529.9 88.6%   
Net profit margin %7.812.0 65.6%  
BALANCE SHEET DATA
Current assets Rs m2,2319,731 22.9%   
Current liabilities Rs m1,2964,698 27.6%   
Net working cap to sales %8.525.0 34.1%  
Current ratio x1.72.1 83.1%  
Inventory Days Days1838 47.2%  
Debtors Days Days213 17.7%  
Net fixed assets Rs m3,32113,721 24.2%   
Share capital Rs m917834 110.0%   
"Free" reserves Rs m2,87815,247 18.9%   
Net worth Rs m3,79516,080 23.6%   
Long term debt Rs m0833 0.0%   
Total assets Rs m5,55123,451 23.7%  
Interest coverage x28.410.2 279.3%   
Debt to equity ratio x00.1 0.0%  
Sales to assets ratio x2.00.9 230.1%   
Return on assets %16.311.9 137.1%  
Return on equity %22.715.0 151.4%  
Return on capital %32.022.5 142.0%  
Exports to sales %00-   
Imports to sales %00.5 0.0%   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNA101 0.0%   
Fx inflow Rs m1,905220 864.9%   
Fx outflow Rs m360101 354.6%   
Net fx Rs m1,545119 1,300.1%   
CASH FLOW
From Operations Rs m1,4454,560 31.7%  
From Investments Rs m-1,079-2,873 37.6%  
From Financial Activity Rs m-260-2,832 9.2%  
Net Cashflow Rs m105-1,145 -9.2%  

Share Holding

Indian Promoters % 49.4 52.6 94.0%  
Foreign collaborators % 1.6 2.0 79.3%  
Indian inst/Mut Fund % 7.3 34.9 21.0%  
FIIs % 1.0 25.4 3.7%  
ADR/GDR % 0.0 0.0 -  
Free float % 49.0 45.4 107.9%  
Shareholders   51,448 149,901 34.3%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare INDRAPRASTHA MEDICAL With:   APOLLO HOSPITALS    KIMS    METROPOLIS HEALTHCARE    NARAYANA HRUDAYALAYA    KOVAI MEDICAL    


More on INDRAPRASTHA MEDICAL vs DR. LAL PATHLABS

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

INDRAPRASTHA MEDICAL vs DR. LAL PATHLABS Share Price Performance

Period INDRAPRASTHA MEDICAL DR. LAL PATHLABS S&P BSE HEALTHCARE
1-Day 4.73% -0.28% 1.18%
1-Month -7.69% -2.16% -0.75%
1-Year 123.05% 24.99% 61.82%
3-Year CAGR 47.02% -4.74% 18.16%
5-Year CAGR 34.76% 16.06% 19.79%

* Compound Annual Growth Rate

Here are more details on the INDRAPRASTHA MEDICAL share price and the DR. LAL PATHLABS share price.

Moving on to shareholding structures...

The promoters of INDRAPRASTHA MEDICAL hold a 51.0% stake in the company. In case of DR. LAL PATHLABS the stake stands at 54.6%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of INDRAPRASTHA MEDICAL and the shareholding pattern of DR. LAL PATHLABS.

Finally, a word on dividends...

In the most recent financial year, INDRAPRASTHA MEDICAL paid a dividend of Rs 3.0 per share. This amounted to a Dividend Payout ratio of 31.9%.

DR. LAL PATHLABS paid Rs 12.0, and its dividend payout ratio stood at 41.5%.

You may visit here to review the dividend history of INDRAPRASTHA MEDICAL, and the dividend history of DR. LAL PATHLABS.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.